Chelsea Therapeutics Internatio (NASDAQ:CHTP) shares spiked 22 percent, following the news that the firm’s Northera treatment for Neurogenic Orthostatic Hypotension performed well in two Phase 3 trials. Neurogenic OH is a chronic disorder that causes symptoms of lightheadedness, dizziness, blurred vision, fatigue, poor concentration and fainting episodes. Chelsea shares closed up 19.08 percent at $1.56, and have been trading between $1.05 and $6.06 in the last 52 weeks.
Ligand Pharmaceuticals Incorpor (NASDAQ:LGND) shares closed up13.33 percent at $16.49, and have been trading between $10.16 and $18.74 in a 52-week range.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stocks closed at $11.68, which is up 11.24 percent, having traded in a 52-week range between $1.23 and $10.50.
ProShares UltraPro Short QQQ (NASDAQ:SQQQ) stocks closed up 7.47 percent at $50.81.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.